Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors? (Q36453763)

14 August 2017

1 reference

title

Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors? (English)

1 reference

14 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

23 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

23 October 2022

author name string

D. A. Gewirtz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662508

23 October 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

14 August 2017

27 November 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1662508

full work available at URL

23 October 2022

https://api.elsevier.com/content/article/PII:000629529190227V?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

https://api.elsevier.com/content/article/PII:000629529190227V?httpAccept=text/plain

23 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

23 October 2022

published in

Biochemical Pharmacology

1 reference

14 August 2017

volume

42

1 reference

14 August 2017

issue

12

1 reference

14 August 2017

page(s)

2253-2258

1 reference

Recent studies of DNA topoisomerases

14 August 2017

cites work

4

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe

23 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Topoisomerase II is a structural component of mitotic chromosome scaffolds.

23 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

23 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide.

23 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

DNA double-strand breaks in mammalian cells after exposure to intercalating agents

23 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Uncoupling the DNA cleavage and religation activities of topoisomerase II with a single-stranded nucleic acid substrate: evidence for an active enzyme-cleaved DNA intermediate

23 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

DNA topoisomerase poisons as antitumor drugs

23 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide

23 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Further characterization of drug-sensitivity and cross-resistance profiles of cloned cell lines of Adriamycin-sensitive and -resistant P388 leukemia

23 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs

23 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells

23 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationship

23 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).

23 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity

23 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26.

23 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Mutational alteration of the breakage/resealing subunit of bacteriophage T4 DNA topoisomerase confers resistance to antitumor agent m-AMSA.

23 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Inhibition of epipodophyllotoxin cytotoxicity by interference with topoisomerase-mediated DNA cleavage

23 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Cell cycle stage dependent variations in drug-induced topoisomerase II mediated DNA cleavage and cytotoxicity

23 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Topoisomerase-specific drug sensitivity in relation to cell cycle progression

23 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Relationship between sensitivity to 4'-(9-acridinylamino)methanesulfon-m-anisidide and DNA topoisomerase II in a cold-sensitive cell-cycle mutant of a murine mastocytoma cell line

23 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Protein-associated deoxyribonucleic acid strand breaks produced in mouse leukemia L1210 cells by ellipticine and 2-methyl-9-hydroxyellipticinium

23 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Stimulation of the topoisomerase II induced DNA cleavage sites in the c-myc protooncogene by antitumor drugs is associated with gene expression

23 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417.

23 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin.

23 October 2022

49

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Effects of dimethyl sulfoxide and thiourea upon intercalator-induced DNA single-strand breaks in mouse leukemia (L1210) cells

23 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Biochemical lesions in DNA associated with the antiproliferative effects of mitoxantrone in the hepatoma cell

23 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Abrogation of etoposide-mediated cytotoxicity by cycloheximide

23 October 2022

54

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Inhibition of protein synthesis reduces the cytotoxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide without affecting DNA breakage and DNA topoisomerase II in a murine mastocytoma cell line

23 October 2022

55

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Protection of doxorubicin cytotoxicity by cycloheximide

23 October 2022

56

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant hu

23 October 2022

58

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Relationship between topoisomerase II and radiosensitivity in mouse L5178Y lymphoma strains.

23 October 2022

59

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin

23 October 2022

61

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide

23 October 2022

62

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons

23 October 2022

66

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Induction of fos RNA by DNA-damaging agents

23 October 2022

70

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Inhibition of c-myc expression in human promyelocytic leukemia and colon adenocarcinoma cells by 6-thioguanine

23 October 2022

73

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Cell death induced by topoisomerase inhibitors. Role of calcium in mammalian cells

23 October 2022

75

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells

23 October 2022

77

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90227-V

23 October 2022

Identifiers

1 reference

14 August 2017

1 reference